scholarly journals P2.06-006 Phase I/II Dose Escalation Study of L-DOS47 as a Monotherapy in Non-Squamous Non-Small Cell Lung Cancer Patients

2017 ◽  
Vol 12 (1) ◽  
pp. S1071-S1072 ◽  
Author(s):  
Rodryg Ramlau ◽  
Dariusz Kowalski ◽  
Cezary Szczylik ◽  
Aleksandra Szczęsna ◽  
Elzbieta Wiatr ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase I ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Dose Escalation ◽  
Small Cell ◽  
Small Cell Lung ◽  
Dose Escalation Study ◽  
Lung Cancer Patients

PO-1844 Adaptive dose escalation for non-small cell lung cancer patients treated with VMAT

2021 ◽  
Vol 161 ◽  
pp. S1572-S1573
Author(s):  
N.S. Tambe ◽  
I.M. Pires ◽  
C. Moore ◽  
A. Wieczorek ◽  
S. Upadhyay ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Dose Escalation ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients

Treatment of non-small cell lung cancer patients with the trifunctional monoclonal antibody catumaxomab (anti-EpCAM × anti-CD3): a phase I study

2007 ◽  
Vol 56 (10) ◽  
pp. 1637-1644 ◽  
Author(s):  
Martin Sebastian ◽  
Bernward Passlick ◽  
Hilke Friccius-Quecke ◽  
Michael Jäger ◽  
Horst Lindhofer ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Monoclonal Antibody ◽  
Phase I ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Phase I Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients

Phase I dose escalation study of amrubicin plus paclitaxel in previously treated advanced non-small cell lung cancer

2015 ◽  
Vol 21 (2) ◽  
pp. 240-247 ◽  
Author(s):  
Kyoichi Kaira ◽  
Noriaki Sunaga ◽  
Hisao Imai ◽  
Yosuke Kamide ◽  
Yasuhiko Koga ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase I ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Dose Escalation ◽  
Small Cell ◽  
Small Cell Lung ◽  
Dose Escalation Study ◽  
Previously Treated
Sign in / Sign up

Export Citation Format

Share Document